Hyperhidrosis is not contagious. It cannot be spread through touch, shared surfaces, or any other form of contact. The American Academy of Dermatology confirms this plainly: hyperhidrosis is not caused by a virus, bacterium, or any other pathogen. It is a neurological condition rooted in how your body’s nervous system communicates with your sweat glands.
What Actually Causes Hyperhidrosis
There are two types of hyperhidrosis, and neither one involves an infectious agent. Primary hyperhidrosis, the more common form, happens when faulty nerve signals cause sweat glands to become overactive. The problem traces back to the sympathetic nervous system, which is the part of your automatic “behind the scenes” wiring that controls things like heart rate, digestion, and sweating. In people with hyperhidrosis, the brain’s sweat control center appears to overreact to both heat and emotional triggers, sending amplified signals down the nerve chain to sweat glands that are structurally normal but working far harder than they need to.
Primary hyperhidrosis typically affects specific areas: palms, soles of the feet, underarms, and sometimes the face. It often starts in childhood or adolescence and has no underlying medical cause.
Secondary hyperhidrosis is triggered by something else going on in the body. Thyroid disorders, diabetes, menopause, and certain medications (including some antidepressants, pain relievers, and hormonal drugs) can all cause widespread excessive sweating. This type tends to affect larger areas of the body rather than specific spots, and it usually begins in adulthood. Even in these cases, the sweating itself poses zero risk of transmission to another person.
Why People Wonder About Contagion
The concern likely comes from the fact that constantly damp skin can develop secondary problems that do look like infections. Skin that stays wet for long periods is more vulnerable to fungal growth, bacterial overgrowth, and conditions like pitted keratolysis (small craters on the soles of the feet caused by bacteria thriving in moisture). These secondary skin infections can be contagious on their own, but they are consequences of the moisture, not part of hyperhidrosis itself. The sweating condition and any infection that follows are separate issues requiring separate treatment.
The Genetic Connection
If you’ve noticed hyperhidrosis running in your family, that’s not coincidence. Research published in BMJ Case Reports found that about 36% of patients with hyperhidrosis have a positive family history, and 58% of familial cases follow a vertical inheritance pattern, meaning a parent passes it directly to a child. Both sexes are equally affected. Most cases with a genetic link follow an autosomal dominant pattern: you only need to inherit the relevant gene variant from one parent, not both, for the condition to appear.
That said, most individual cases are sporadic, meaning they show up without any obvious family pattern. Having a parent with hyperhidrosis raises your odds, but plenty of people develop it with no family history at all.
How Severity Is Measured
Doctors use a simple four-point scale called the Hyperhidrosis Disease Severity Scale to gauge how much sweating disrupts your life. A score of 1 means sweating is barely noticeable and doesn’t get in the way. A score of 2 means it’s tolerable but sometimes interferes with daily activities. Scores of 3 or 4 indicate sweating that is barely tolerable to intolerable and consistently disrupts normal routines. A score of 3 or higher is considered severe and typically warrants treatment.
Treatment Options
Because hyperhidrosis is driven by overactive nerve signaling rather than infection, treatments focus on blocking or calming that signal at various points in the chain.
Topical treatments have expanded significantly in recent years. In summer 2024, the FDA approved a gel (sofpironium bromide) for underarm hyperhidrosis that works by blocking the receptor where nerve signals tell sweat glands to activate. In Europe, a cream containing glycopyrronium bromide was approved for underarm sweating in 12 countries. Studies showed that after eight days of use, 60% of patients reported meaningful quality-of-life improvement. The most common side effect was dry mouth, occurring in about 16% of users.
Botulinum toxin injections remain a well-established option, particularly for the underarms, palms, and face. For facial hyperhidrosis, both topical glycopyrrolate and botulinum toxin injections achieved complete response in 75% of cases in a 2022 comparison study. The key difference: the topical version worked faster and avoided needles, while injections lasted longer, with effects holding for up to six months.
For secondary hyperhidrosis, treatment targets the underlying cause. Adjusting a medication, managing a thyroid condition, or addressing hormonal changes can reduce or eliminate the excessive sweating entirely.